Issue Price
₹140
Per Share
GMP
NIL
Grey Market
Est. Listing
₹140
Expected Price
Min. Application
₹280,000
2 lots × 1000 shares
Global Longlife Hospital and Research Limited provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers (" NABH Accredited").The company is known as a Multi-Speciality Tertiary Care Hospital of Gujarat with 110 beds well equipped for Medical & Surgical Specialities. As of December 31, 2021, the company has 11 full-time consultants, and a team of more than 30 experienced doctors as consultants to serve patients. The company's staff strength also comprises 37 nurses and more than 50 paramedical, pharmacists, corporate and support staff. Global Longlife Hospital is located in Ahmedabad.Competitive Strengths:Constant innovation.Technical expertise.
Global Longlife Hospital & Research Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 176,000 | — | ₹2.46 Cr | — |
| TOTAL | 3,500,000 | 100.00% | ₹49.00 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹140,000 |
| Retail (Max) | 13 | 13,000 | ₹1,820,000 |
| sNII (Min) | 14 | 14,000 | ₹1,960,000 |
| bNII (Min) | 68 | 68,000 | ₹9,520,000 |
| Particulars | 31-Dec-21 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue from Operations | 2674.28 | 3276.59 | 3365.66 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 386.31 | 103.54 | -86.24 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 4001.04 | 3590.39 | 4191.69 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |